DaVita Overview

  • Year Founded
  • 1979

Year Founded

  • Status
  • Public

  • Employees
  • 78,000

Employees

  • Stock Symbol
  • DVA

Stock Symbol

  • Investments
  • 68

  • Share Price
  • $161.03
  • (As of Friday Closing)

DaVita General Information

Description

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Contact Information

Website
www.davita.com
Formerly Known As
Total Renal Care Holdings
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 2000 16th Street
  • Denver, CO 80202
  • United States
+1 (888)
Primary Industry
Hospitals/Inpatient Services
Other Industries
Other Healthcare Services
Clinics/Outpatient Services
Stock Exchange
NYS
Corporate Office
  • 2000 16th Street
  • Denver, CO 80202
  • United States
+1 (888)

DaVita Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DaVita Stock Performance

As of 20-Nov-2026, DaVita’s stock price is $161.03. Its current market cap is $10.1B with 62.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$161.03 $156.34 $101.00 - $247.49 $10.1B 62.9M 737K $13.86

DaVita Financials Summary

As of 30-Sep-2026, DaVita has a trailing 12-month revenue of $14.2B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 25,722,027 21,975,308 25,206,138 21,863,237
Revenue 14,167,545 13,643,069 12,815,550 12,140,147
EBITDA 2,808,893 2,642,097 2,724,722 2,321,088
Net Income 920,075 746,803 936,342 691,535
Total Assets 17,816,512 17,480,103 17,285,268 16,893,578
Total Debt 13,392,426 12,874,331 12,066,836 11,116,421
Public Fundamental Data provided by Morningstar, Inc. disclaimer

DaVita Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DaVita‘s full profile, request access.

Request a free trial

DaVita Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%.
Hospitals/Inpatient Services
Denver, CO
78,000 As of 2025

Bad Homburg, Germany
 

Birmingham, AL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DaVita Competitors (3)

One of DaVita’s 3 competitors is Fresenius Medical Care, a Corporation company based in Bad Homburg, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fresenius Medical Care Corporation Bad Homburg, Germany
Encompass Health Corporation Birmingham, AL
Fresenius Corporation Bad Homburg, Germany
You’re viewing 3 of 3 competitors. Get the full list »

DaVita Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DaVita Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore DaVita‘s full profile, request access.

Request a free trial

DaVita Investments & Acquisitions (68)

DaVita’s most recent deal was a PE Growth/Expansion with Elara Caring. The deal was made on 02-Feb-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Elara Caring 02-Feb-2026 PE Growth/Expansion Elder and Disabled Care
Fresenius Medical Care (Dialysis Clinic Businesses in Brazil, Colombia, Chile, Ecuado) 01-Aug-2025 Merger/Acquisition Clinics/Outpatient Services
Baijun Medical Treatment 01-Oct-2024 Secondary Transaction - Private Hospitals/Inpatient Services
Egenesis 04-Sep-2024 Later Stage VC Drug Discovery
Baijun Medical Treatment 24-May-2024 Secondary Transaction - Private Hospitals/Inpatient Services
You’re viewing 5 of 68 investments and acquisitions. Get the full list »

DaVita ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

18.77 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Services

Subindustry

of 97

Rank

Percentile

To view DaVita’s complete esg history, request access »

DaVita Exits (9)

DaVita’s most recent exit was on 01-Mar-2016 from Optum Care Washington (Hospitals/Inpatient Services). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Optum Care Washington (Hospitals/Inpatient Services) 01-Mar-2016 Completed
DaVita Care (India) 23-Jan-2014 Completed
CVRx 30-Oct-2013 Completed
  • 6 buyers
Lifeline Vascular Care 31-Jul-2013 Completed
DaVita Medical Group 01-Nov-2012 Merger/Acquisition Completed
You’re viewing 5 of 9 exits. Get the full list »

DaVita Affiliates

Subsidiaries (40)

Name Industry Location Year Founded
DaVita Venture Group Denver, CO 2020
Bemity Dialysis Denver, CO 2018
Lifeline Vascular Center-Albany Denver, CO 2017
Open Access Lifeline Miami, FL 2017
Meesa Dialysis Isle, MN 2015
You’re viewing 5 of 40 affiliates. Get the full list.  »

DaVita FAQs

  • When was DaVita founded?

    DaVita was founded in 1979.

  • Where is DaVita headquartered?

    DaVita is headquartered in Denver, CO.

  • What is the size of DaVita?

    DaVita has 78,000 total employees.

  • What industry is DaVita in?

    DaVita’s primary industry is Hospitals/Inpatient Services.

  • Is DaVita a private or public company?

    DaVita is a Public company.

  • What is DaVita’s stock symbol?

    The ticker symbol for DaVita is DVA.

  • What is the current stock price of DaVita?

    As of 20-Nov-2026 the stock price of DaVita is $161.03.

  • What is the current market cap of DaVita?

    The current market capitalization of DaVita is $10.1B.

  • What is DaVita’s current revenue?

    The trailing twelve month revenue for DaVita is $14.2B.

  • Who are DaVita’s competitors?

    Fresenius Medical Care, Encompass Health, and Fresenius are competitors of DaVita.

  • What is DaVita’s annual earnings per share (EPS)?

    DaVita’s EPS for 12 months was $13.86.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process